X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-12 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $385.42 | -8,358 | 29,678 | -22% | -$3,221,340 | |||||
| DM | 2024-07-29 | HCA | Whalen Kathleen M | SVP, Chief Ethics Officer | S - Sale+OE | $362.13 | -4,851 | 9,454 | -34% | -$1,756,695 | |||||
2024-07-29 | HCA | Reiner Deborah M | SVP - Mktg., Communications | S - Sale | $359.96 | -3,314 | 3,510 | -49% | -$1,192,914 | ||||||
| D | 2024-07-29 | HCA | Wyatt Christopher F. | SVP, Controller | S - Sale+OE | $360.20 | -4,000 | 40,449 | -9% | -$1,440,782 | |||||
2024-07-25 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale | $355.05 | -1,857 | 17,755 | -9% | -$659,328 | ||||||
| D | 2024-05-16 | HCA | Whalen Kathleen M | SVP, Chief Ethics Officer | S - Sale+OE | $326.30 | -3,204 | 11,318 | -22% | -$1,045,465 | |||||
2024-05-15 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale | $326.18 | -1,863 | 19,612 | -9% | -$607,673 | ||||||
2024-05-09 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale | $316.88 | -6,311 | 29,624 | -18% | -$1,999,825 | ||||||
2024-05-09 | HCA | Cohen Jeffrey E. | SVP-Government Relations | S - Sale | $313.00 | -1,650 | 5,185 | -24% | -$516,450 | ||||||
| D | 2024-05-06 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $309.00 | -1,600 | 35,935 | -4% | -$494,400 | |||||
| M | 2024-05-02 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale | $312.00 | -1,863 | 21,475 | -8% | -$581,256 | |||||
| DM | 2024-03-18 | HCA | Wasserman Chad J | SVP, CIO | S - Sale+OE | $327.92 | -1,220 | 1,576 | -44% | -$400,057 | |||||
2024-02-09 | HCA | Whalen Kathleen M | SVP, Chief Ethics Officer | S - Sale | $306.21 | -4,262 | 10,250 | -29% | -$1,305,074 | ||||||
2024-02-05 | HCA | Wyatt Christopher F. | SVP, Controller | S - Sale | $312.42 | -4,000 | 37,383 | -10% | -$1,249,680 | ||||||
| D | 2024-02-06 | HCA | Rutherford Bill B | CFO, EVP | S - Sale+OE | $310.63 | -6,000 | 168,282 | -3% | -$1,863,780 | |||||
| D | 2024-02-05 | HCA | Mosier Sammie S | SVP, Chief Nurse Exec | S - Sale+OE | $312.00 | -1,645 | 7,646 | -18% | -$513,240 | |||||
| D | 2024-02-02 | HCA | Wasserman Chad J | SVP, CIO | S - Sale+OE | $312.04 | -652 | 379 | -63% | -$203,451 | |||||
| D | 2024-01-31 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale+OE | $307.00 | -3,861 | 19,625 | -16% | -$1,185,327 | |||||
| D | 2024-01-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $306.79 | -3,200 | 24,929 | -11% | -$981,734 | |||||
2023-08-14 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale | $269.12 | -5,204 | 19,760 | -21% | -$1,400,516 | ||||||
2023-08-11 | HCA | Cohen Jeffrey E. | SVP-Government Relations | S - Sale | $270.00 | -1,500 | 4,414 | -25% | -$405,000 | ||||||
2023-08-03 | HCA | Whalen Kathleen M | SVP, Chief Ethics Officer | S - Sale | $270.00 | -2,916 | 10,250 | -22% | -$787,320 | ||||||
2023-04-28 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale | $284.44 | -12,556 | 28,783 | -30% | -$3,571,396 | ||||||
2023-04-28 | HCA | Akdamar Erol R | Group Pres | S - Sale | $285.00 | -3,500 | 102,484 | -3% | -$997,500 | ||||||
2023-04-24 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale | $288.38 | -4,473 | 22,243 | -17% | -$1,289,913 | ||||||
| D | 2023-04-14 | HCA | Paslick P. Martin | SVP, CIO | S - Sale+OE | $275.00 | -2,687 | 151,642 | -2% | -$738,925 | |||||
2023-04-10 | HCA | Paslick P. Martin | SVP, CIO | S - Sale | $270.00 | -2,539 | 151,642 | -2% | -$685,530 | ||||||
| D | 2023-04-04 | HCA | Paslick P. Martin | SVP, CIO | S - Sale+OE | $265.00 | -3,034 | 154,181 | -2% | -$804,010 | |||||
2023-02-17 | HCA | Whalen Kathleen M | SVP, Chief Ethics Officer | S - Sale | $263.61 | -1,734 | 13,166 | -12% | -$457,097 | ||||||
2023-02-07 | HCA | Berres Jennifer | SVP, Chief Human Res. Officer | S - Sale | $255.23 | -4,000 | 7,392 | -35% | -$1,020,912 | ||||||
2023-02-03 | HCA | Reiner Deborah M | SVP - Mktg., Communications | S - Sale | $257.61 | -7,941 | 0 | -100% | -$2,045,699 | ||||||
| D | 2023-02-02 | HCA | Akdamar Erol R | Group Pres | S - Sale+OE | $258.63 | -3,000 | 99,794 | -3% | -$775,891 | |||||
| D | 2023-02-03 | HCA | Rutherford Bill B | CFO, EVP | S - Sale+OE | $258.19 | -30,000 | 150,272 | -17% | -$7,745,568 | |||||
| D | 2023-02-01 | HCA | Wyatt Christopher F. | SVP, Controller | S - Sale+OE | $253.30 | -4,900 | 32,392 | -13% | -$1,241,170 | |||||
| D | 2023-02-01 | HCA | Paslick P. Martin | SVP, CIO | S - Sale+OE | $256.95 | -1,000 | 149,145 | -1% | -$256,949 | |||||
| D | 2023-01-30 | HCA | McManus Timothy M | Group Pres | S - Sale+OE | $254.06 | -7,900 | 13,987 | -36% | -$2,007,067 | |||||
| D | 2023-02-01 | HCA | Foster Jon M | EVP, COO | S - Sale+OE | $251.98 | -16,424 | 128,839 | -11% | -$4,138,480 | |||||
| D | 2023-02-01 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $257.11 | -4,000 | 20,823 | -16% | -$1,028,440 | |||||
2022-11-11 | HCA | Moore A Bruce Jr | Group Pres - Service Line | S - Sale | $224.07 | -10,000 | 383,586 | -3% | -$2,240,690 | ||||||
| D | 2022-10-28 | HCA | Hall Charles J | Group Pres | S - Sale+OE | $223.50 | -9,838 | 204,408 | -5% | -$2,198,793 | |||||
2022-10-28 | HCA | Sowell Joseph A III | SVP; Chief Development Officer | S - Sale | $223.18 | -12,946 | 37,771 | -26% | -$2,889,304 | ||||||
| D | 2022-10-28 | HCA | Billington Phillip G | SVP-Internal Audit Services | S - Sale+OE | $222.58 | -8,332 | 40,652 | -17% | -$1,854,518 | |||||
2022-10-24 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align. | S - Sale | $203.30 | -2,000 | 20,372 | -9% | -$406,605 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |